File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Poor prognosis associated with venous thromboembolism in Asian patients with ovarian clear cell carcinoma

TitlePoor prognosis associated with venous thromboembolism in Asian patients with ovarian clear cell carcinoma
Authors
KeywordsOvarian carcinoma
Clear cell
Venous thromboembolism
Issue Date2018
PublisherI.R.O.G. Canada Inc. The Journal's web site is located at https://ejgo.imrpress.com/EN/0392-2936/home.shtml
Citation
European Journal of Gynaecological Oncology, 2018, v. 39 n. 6, p. 903-910 How to Cite?
AbstractPurpose of Investigation: To evaluate the incidence and prognostic implications of venous thromboembolism (VTE) in Asian patients with ovarian clear cell carcinoma (CCC). Materials and Methods: Between July 1987 and December 2005, 144 CCC patients were identified. The clinical outcomes of those with (case) and without (control) VTE were analyzed retrospectively. Results: After a mean follow-up of 131.2 ± 52.2 months, 11.1% (16/144) developed VTE and only one occurred in the perioperative period. Compared to the control, the case group was less responsive to chemotherapy (57.1% vs. 85.1%, p = 0.01) with shorter duration of response to chemotherapy (4.7 months vs. 83.6 months; p < 0.001), higher recurrence / progressive disease rate (100.0% vs. 37.2%, p < 0.001), shorter median disease-free survival (DFS) (0 months vs. 70.8 months; p < 0.001), and overall survival (OS) (16.5 months vs. 88.0 months; p < 0.001). The median interval from the diagnosis of VTE to death was 43.0 (range 1–394) days, and the 60-day mortality rate was 56.3%. Multivariate analysis showed that duration of chemotherapy response for more than one year was independently correlated with the DFS, while VTE, stage, and the chemotherapy response duration were independent prognosticators for OS. Conclusion: VTE is rare in Asian patients with CCC and care is needed when giving it to these patients in view of possible haemorrhagic complications. When VTE occurs, it is associated with high mortality.
Persistent Identifierhttp://hdl.handle.net/10722/281818
ISSN
2019 Impact Factor: 0.215
2015 SCImago Journal Rankings: 0.307

 

DC FieldValueLanguage
dc.contributor.authorTse, KY-
dc.contributor.authorIp, PCP-
dc.contributor.authorLau, SK-
dc.contributor.authorNg, TY-
dc.contributor.authorTam, KF-
dc.contributor.authorCheung, ANY-
dc.contributor.authorNgan, HYS-
dc.date.accessioned2020-03-27T04:22:53Z-
dc.date.available2020-03-27T04:22:53Z-
dc.date.issued2018-
dc.identifier.citationEuropean Journal of Gynaecological Oncology, 2018, v. 39 n. 6, p. 903-910-
dc.identifier.issn0392-2936-
dc.identifier.urihttp://hdl.handle.net/10722/281818-
dc.description.abstractPurpose of Investigation: To evaluate the incidence and prognostic implications of venous thromboembolism (VTE) in Asian patients with ovarian clear cell carcinoma (CCC). Materials and Methods: Between July 1987 and December 2005, 144 CCC patients were identified. The clinical outcomes of those with (case) and without (control) VTE were analyzed retrospectively. Results: After a mean follow-up of 131.2 ± 52.2 months, 11.1% (16/144) developed VTE and only one occurred in the perioperative period. Compared to the control, the case group was less responsive to chemotherapy (57.1% vs. 85.1%, p = 0.01) with shorter duration of response to chemotherapy (4.7 months vs. 83.6 months; p < 0.001), higher recurrence / progressive disease rate (100.0% vs. 37.2%, p < 0.001), shorter median disease-free survival (DFS) (0 months vs. 70.8 months; p < 0.001), and overall survival (OS) (16.5 months vs. 88.0 months; p < 0.001). The median interval from the diagnosis of VTE to death was 43.0 (range 1–394) days, and the 60-day mortality rate was 56.3%. Multivariate analysis showed that duration of chemotherapy response for more than one year was independently correlated with the DFS, while VTE, stage, and the chemotherapy response duration were independent prognosticators for OS. Conclusion: VTE is rare in Asian patients with CCC and care is needed when giving it to these patients in view of possible haemorrhagic complications. When VTE occurs, it is associated with high mortality.-
dc.languageeng-
dc.publisherI.R.O.G. Canada Inc. The Journal's web site is located at https://ejgo.imrpress.com/EN/0392-2936/home.shtml-
dc.relation.ispartofEuropean Journal of Gynaecological Oncology-
dc.subjectOvarian carcinoma-
dc.subjectClear cell-
dc.subjectVenous thromboembolism-
dc.titlePoor prognosis associated with venous thromboembolism in Asian patients with ovarian clear cell carcinoma-
dc.typeArticle-
dc.identifier.emailTse, KY: tseky@hku.hk-
dc.identifier.emailIp, PCP: philipip@hku.hk-
dc.identifier.emailLau, SK: lsk382@hkucc.hku.hk-
dc.identifier.emailNg, TY: tyng@hkucc.hku.hk-
dc.identifier.emailTam, KF: tamkf@hkucc.hku.hk-
dc.identifier.emailCheung, ANY: anycheun@hkucc.hku.hk-
dc.identifier.emailNgan, HYS: hysngan@hkucc.hku.hk-
dc.identifier.authorityTse, KY=rp02391-
dc.identifier.authorityIp, PCP=rp01890-
dc.identifier.authorityCheung, ANY=rp00542-
dc.identifier.authorityNgan, HYS=rp00346-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.12892/ejgo3972.2018-
dc.identifier.scopuseid_2-s2.0-85058844325-
dc.identifier.hkuros309529-
dc.identifier.volume39-
dc.identifier.issue6-
dc.identifier.spage903-
dc.identifier.epage910-
dc.publisher.placeCanada-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats